Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents

  • Ulrikka Nygaard
    Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • Mette Holm
    Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N, Denmark
  • Cathrine Bohnstedt
    Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • Qing Chai
    Department of Paediatrics and Adolescent Medicine, Regionshospital Nordjylland, Hjoerring, Denmark
  • Lisbeth Samsø Schmidt
    Department of Paediatrics and Adolescent Medicine, Herlev Hospital, Herlev, Denmark
  • Ulla Birgitte Hartling
    Department of Paediatrics and Adolescent Medicine, Odense University Hospital, Odense, Denmark
  • Jens Jakob Herrche Petersen
    Department of Paediatrics and Adolescent Medicine, Southwest Jutland Hospital Esbjerg, Esbjerg, Denmark
  • Jesper Thaarup
    Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Jesper Bjerre
    Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N, Denmark
  • Niels Grove Vejlstrup
    Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • Klaus Juul
    Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
  • Lone Graff Stensballe
    Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

抄録

<jats:p>In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12–17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ